|1.||Yamamoto, Naoki: 2 articles (01/2012 - 09/2008)|
|2.||Nishikawa, Toru: 2 articles (01/2012 - 09/2008)|
|3.||Dolmatova, Elena: 1 article (11/2012)|
|4.||Baum, Jennifer R: 1 article (11/2012)|
|5.||Sorgen, Paul L: 1 article (11/2012)|
|6.||Ambrosi, Cinzia: 1 article (11/2012)|
|7.||Sosinsky, Gina E: 1 article (11/2012)|
|8.||Boassa, Daniela: 1 article (11/2012)|
|9.||Spagnol, Gaelle: 1 article (11/2012)|
|10.||Keith, Kimberly: 1 article (11/2012)|
|1.||Schizophrenia (Dementia Praecox)
01/01/2012 - "We showed that the conserved cytoplasmic tail of the IgG BCR, which contains a putative PDZ (postsynaptic density 95/disc large/zona occludens 1)-binding motif, associated with synapse-associated protein 97 (SAP97), a PDZ domain-containing scaffolding molecule that is involved in controlling receptor density and signal strength at neuronal synapses. "
11/01/2008 - "Using surface plasmon resonance, we studied the interaction of members of all four MAGUK subfamilies--synapse-associated protein 97 (SAP97), calcium/calmodulin-dependent serine protein kinase (CASK), membrane palmitoylated protein 2 (MPP2), and zona occludens (ZO) 1--and calmodulin to determine interaction affinities and localize the binding site. "
|5.||Alzheimer Disease (Alzheimer's Disease)
11/01/2010 - "Interfering with the ADAM10/synapse-associated protein 97 complex for 2 weeks by means of a cell-permeable peptide strategy is sufficient to shift the metabolism of the amyloid precursor protein towards amyloidogenesis and allows the reproduction of initial phases of sporadic Alzheimer's disease. "
|2.||Protein Kinases (Protein Kinase)
|3.||Immunoglobulin G (IgG)
|4.||Calmodulin (Calcium-Dependent Activator Protein)
|6.||Amyloid (Amyloid Fibrils)